{"id":"https://openalex.org/W2017069590","doi":"https://doi.org/10.1016/s0197-2456(00)00058-1","title":"Phase II Clinical Trial Design for Noncytotoxic Anticancer Agents for Which Time to Disease Progression Is the Primary Endpoint","display_name":"Phase II Clinical Trial Design for Noncytotoxic Anticancer Agents for Which Time to Disease Progression Is the Primary Endpoint","publication_year":2000,"publication_date":"2000-08-01","ids":{"openalex":"https://openalex.org/W2017069590","doi":"https://doi.org/10.1016/s0197-2456(00)00058-1","mag":"2017069590","pmid":"https://pubmed.ncbi.nlm.nih.gov/10913809"},"language":"en","primary_location":{"id":"doi:10.1016/s0197-2456(00)00058-1","doi":"https://doi.org/10.1016/s0197-2456(00)00058-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0197-2456(00)00058-1","pdf_url":null,"source":{"id":"https://openalex.org/S84962792","display_name":"Controlled Clinical Trials","issn_l":"0197-2456","issn":["0197-2456","1879-050X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled Clinical Trials","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1016/s0197-2456(00)00058-1","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112782077","display_name":"Rosemarie Mick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Rosemarie Mick","raw_affiliation_strings":["Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. rmick@cceb.upenn.edu","Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA,USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. rmick@cceb.upenn.edu","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA,USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103408877","display_name":"John J. Crowley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089486","display_name":"Fred Hutch Cancer Center","ror":"https://ror.org/007ps6h72","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210089486"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John J Crowley","raw_affiliation_strings":["Program in Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Program in Biostatistics, Fred Hutchinson Cancer Research Center, Seattle, WA USA","institution_ids":["https://openalex.org/I4210089486"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000822072","display_name":"Raymond James Carroll","orcid":"https://orcid.org/0000-0002-5465-9682","observed_orcids":["https://orcid.org/0000-0002-5465-9682"]},"institutions":[{"id":"https://openalex.org/I91045830","display_name":"Texas A&M University","ror":"https://ror.org/01f5ytq51","country_code":"US","type":"education","lineage":["https://openalex.org/I91045830"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond J Carroll","raw_affiliation_strings":["Department of Statistics, Texas A&M University, College Station, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Statistics, Texas A&M University, College Station, TX, USA","institution_ids":["https://openalex.org/I91045830"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5112782077"],"corresponding_institution_ids":["https://openalex.org/I79576946"],"apc_list":null,"apc_paid":null,"fwci":3.7442,"has_fulltext":false,"cited_by_count":112,"citation_normalized_percentile":{"value":0.9389002,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"21","issue":"4","first_page":"343","last_page":"359"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13500","display_name":"Probability and Statistical Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/phase-ii-trial-design","display_name":"phase II trial design","score":0.8930000066757202},{"id":"https://openalex.org/keywords/cytostatic-drugs","display_name":"cytostatic agents","score":0.9670000076293945},{"id":"https://openalex.org/keywords/time-to-progression","display_name":"time to progression","score":0.9769999980926514},{"id":"https://openalex.org/keywords/hazard-ratio","display_name":"hazard ratio","score":0.8679999709129333},{"id":"https://openalex.org/keywords/chi-square-test","display_name":"chi-square test","score":0.5609999895095825},{"id":"https://openalex.org/keywords/statistical-power","display_name":"statistical power","score":0.8790000081062317},{"id":"https://openalex.org/keywords/tumor-response-rate","display_name":"tumor response rate","score":0.5370000004768372}],"concepts":[{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.806332528591156},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.5802368521690369},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5730301141738892},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5315888524055481},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5243566036224365},{"id":"https://openalex.org/C2777977315","wikidata":"https://www.wikidata.org/wiki/Q7243056","display_name":"Primary (astronomy)","level":2,"score":0.5074531435966492},{"id":"https://openalex.org/C148482608","wikidata":"https://www.wikidata.org/wiki/Q17007018","display_name":"Clinical study design","level":3,"score":0.4519989490509033},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.42356303334236145},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4154842495918274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3691047728061676},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.09093758463859558},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C1276947","wikidata":"https://www.wikidata.org/wiki/Q333","display_name":"Astronomy","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003198","descriptor_name":"Computer Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012107","descriptor_name":"Research Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015233","descriptor_name":"Models, Statistical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017322","descriptor_name":"Clinical Trials, Phase II as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1016/s0197-2456(00)00058-1","doi":"https://doi.org/10.1016/s0197-2456(00)00058-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0197-2456(00)00058-1","pdf_url":null,"source":{"id":"https://openalex.org/S84962792","display_name":"Controlled Clinical Trials","issn_l":"0197-2456","issn":["0197-2456","1879-050X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled Clinical Trials","raw_type":"journal-article"},{"id":"pmid:10913809","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10913809","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled clinical trials","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.36.1375","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.36.1375","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://stat.tamu.edu/ftp/pub/rjcarroll/2000.papers.directory/rosie.ps","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1016/s0197-2456(00)00058-1","doi":"https://doi.org/10.1016/s0197-2456(00)00058-1","is_oa":true,"landing_page_url":"https://doi.org/10.1016/s0197-2456(00)00058-1","pdf_url":null,"source":{"id":"https://openalex.org/S84962792","display_name":"Controlled Clinical Trials","issn_l":"0197-2456","issn":["0197-2456","1879-050X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Controlled Clinical Trials","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9391000270843506,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2663047892","display_name":"Center for Rural and Environmental Health","funder_award_id":"P30ES009106","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G3359703783","display_name":null,"funder_award_id":"P30 ESO9106","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G911278065","display_name":null,"funder_award_id":"CA 57030","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W65325140","https://openalex.org/W1703159633","https://openalex.org/W1916572113","https://openalex.org/W1958271975","https://openalex.org/W1968420848","https://openalex.org/W1976585131","https://openalex.org/W1984254136","https://openalex.org/W1995286928","https://openalex.org/W2006948168","https://openalex.org/W2029409133","https://openalex.org/W2035068715","https://openalex.org/W2060705256","https://openalex.org/W2068113261","https://openalex.org/W2073680312","https://openalex.org/W2082476295","https://openalex.org/W2084179338","https://openalex.org/W2086750573","https://openalex.org/W2093616734","https://openalex.org/W2118403707","https://openalex.org/W2126551611","https://openalex.org/W2140556790","https://openalex.org/W2146966213","https://openalex.org/W2151957470","https://openalex.org/W2160038605","https://openalex.org/W2168548734","https://openalex.org/W2228536347","https://openalex.org/W2297045001","https://openalex.org/W2324293645","https://openalex.org/W2401795134","https://openalex.org/W2414946148","https://openalex.org/W2796700885","https://openalex.org/W2797066837"],"related_works":["https://openalex.org/W7097598726","https://openalex.org/W2049317433","https://openalex.org/W2490166187","https://openalex.org/W1878731062","https://openalex.org/W2067068593","https://openalex.org/W2050988787","https://openalex.org/W4255964411","https://openalex.org/W2782931979","https://openalex.org/W2081367546","https://openalex.org/W2063887939"],"abstract_inverted_index":{"Phase":[0,78],"II":[1,32,79,100,132],"evaluation":[2,33,80],"is":[3,120,153,173,194,202,221],"a":[4,98,123,130,135,176,185,222,239,246],"critical":[5],"screening":[6],"step":[7],"in":[8],"the":[9,27,39,159,182,192,206,217,230,298],"development":[10],"of":[11,41,81,134,214,225,229,236,261,276,287,297],"new":[12,53,136],"cancer":[13,142],"treatments.":[14],"Historically,":[15],"anticancer":[16,54],"agents":[17,55,64,83],"have":[18,139],"been":[19,35],"cytotoxic;":[20],"they":[21],"kill":[22],"existing":[23],"cells.":[24],"As":[25],"such,":[26],"primary":[28],"endpoint":[29],"for":[30,129,264],"phase":[31,99,131],"has":[34,49,278],"tumor":[36,66,76],"response":[37],"rate,":[38],"percentage":[40],"patients":[42,127,268],"whose":[43],"tumors":[44],"shrink":[45],">":[46],"50%.":[47],"Biotechnology":[48],"led":[50],"to":[51,61,74,93,149,156,204,244,249,256,303],"promising":[52],"that":[56,103,184],"are":[57,72],"cytostatic.":[58],"In":[59],"contrast":[60],"cytotoxics,":[62],"these":[63],"modulate":[65],"environments":[67],"and/or":[68],"cellular":[69],"targets":[70],"and":[71,181,270,281,290],"expected":[73],"delay":[75],"growth.":[77],"such":[82,90],"may":[84,163,165],"instead":[85],"focus":[86],"on":[87,259,285],"failure-time":[88,208],"endpoints,":[89],"as":[91],"time":[92,148],"disease":[94],"progression.":[95],"We":[96],"examine":[97],"trial":[101,247,299],"design":[102,172],"evaluates":[104],"clinical":[105],"benefit":[106],"by":[107,122,175],"comparing":[108],"sequentially":[109],"measured":[110],"paired":[111,207,218,307],"failure":[112,219,308],"times":[113,220],"within":[114],"each":[115],"treated":[116],"patient.":[117],"Clinical":[118],"efficacy":[119],"defined":[121],"hazard":[124,241,253],"ratio.":[125],"Assuming":[126,238],"eligible":[128],"study":[133],"cytostatic":[137,160,186],"agent":[138,187],"failed":[140],"previous":[141],"treatment,":[143],"their":[144],"most":[145],"recent":[146],"prior":[147],"progression":[150,157],"interval,":[151],"TTP(1),":[152],"uncensored.":[154],"Time":[155],"after":[158],"agent,":[161],"TTP(2),":[162],"or":[164],"not":[166],"be":[167,188],"censored":[168],"at":[169],"analysis.":[170],"The":[171,212],"motivated":[174],"\"growth":[177],"modulation":[178],"index\"":[179],"(TTP(2)/TTP(1))":[180],"proposition":[183],"considered":[189],"effective":[190],"if":[191],"index":[193],"greater":[195],"than":[196],"1.33.":[197],"A":[198],"chi(2)":[199],"test":[200,231],"statistic":[201],"employed":[203],"evaluate":[205],"data":[209],"(TTP(1),":[210],"TTP(2)).":[211],"degree":[213],"correlation":[215],"between":[216,306],"key":[223],"feature":[224],"this":[226],"design.":[227],"Power":[228],"was":[232],"evaluated":[233],"through":[234],"simulation":[235],"trials.":[237],"null":[240],"ratio":[242,254],"equal":[243,255],"1.0,":[245],"designed":[248],"detect":[250],"an":[251,272],"alternative":[252],"1.3,":[257],"based":[258,284],"accrual":[260],"25":[262],"patients/year":[263],"2":[265,274],"years":[266,275],"(50":[267],"total)":[269],"with":[271],"additional":[273],"follow-up,":[277],"25%,":[279],"46%,":[280],"83%":[282],"power":[283],"correlations":[286,305],"0.3,":[288],"0.5":[289],"0.7,":[291],"respectively.":[292],"These":[293],"results":[294],"demonstrate":[295],"efficiency":[296],"design,":[300],"given":[301],"moderate":[302],"strong":[304],"times.":[309]},"counts_by_year":[{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}